Inhaltsseite: Home

ZKB Mini-Future Long auf Novo Nordisk -B-, Open End
Novo Nordisk A/S

ISIN: CH1305134277 Security: 130513427 Symbol: INOLQZ Life cycle
Secondary market

Bid Price 1.66

Ask Price 1.67

Currency CHF

Exchange SIX Structured Products

Volume 75'000.00

Volume 75'000.00

Date/time (delayed) 13.06.2024 09:41:07

Sell Buy 

Product Download

Security PDF for download Publication date
Termsheet 13.06.2024
Key Information Document DE 13.06.2024
Key Information Document EN 13.06.2024
Key Information Document FR 13.06.2024
Key Information Document IT 13.06.2024

Price data

  Bid Ask
Price 1.66 1.67
Volume 75'000.00 75'000.00
Date/time 13.06.24 09:41 13.06.24 09:41

Current data

Last price paid 1.66
Change +1.22% [ +0.02 ]
Last traded volume n.a. Unit
Cumulative volume n.a. Unit
Date/time 12.06.2024 17:20

Life cycle

Fixingn.a.
Settlement date31.01.2024
Last tradingn.a.
Final fixingn.a.
Currency redemptionCHF

Performance

Perf. since issue +287.21%
Year to date (YTD) n.a.
1 month +44.35%
3 months +26.72%
1 year n.a.
3 years n.a.

Key figures on issue

Issue price0.43
Underlying price on issue745.70
Premium0.01%
Premium p.a.n.a.
Leveragen.a.
Implied volatilityn.a.

Reference data

ISIN CH1305134277
Symbol INOLQZ
Security 130513427
Exchange SIX Structured Products
Currency CHF
Expiry n.a.
Underlying Novo Nordisk -B-, DK0062498333
Underlying ISIN DK0062498333
Funding level 676.605000
Stop-loss level 702.211400
Distance to stop-loss level 28.98%
Long/Short type Long
Subscription ratio 25.00
Issuer Zürcher Kantonalbank
Exercise type n.a.
Minimum execution n.a.
Value day 29.01.2024

Key figures

Premium 0.87%
Premium p.a. n.a.
Leverage 3.08
Moneyness in-the-money
Leverage n.a.
Delta n.a.
Intrinsic value 312.195000
Break-even n.a.
SSPA value at risk n.a.
SSPA risk rating n.a.

Product type

SSPA derivative category Leverage
SSPA code Mini future (2210)

Ajax loading